Stereotaxis Inc. (NYSE AMERICAN: STXS)
$2.10
+0.0850 ( +4.23% ) 176.1K
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Market Data
Open
$2.10
Previous close
$2.01
Volume
176.1K
Market cap
$173.55M
Day range
$1.99 - $2.10
52 week range
$1.33 - $3.29
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 14, 2023 |
4 | Insider transactions | 1 | Sep 01, 2023 |
4 | Insider transactions | 1 | Aug 30, 2023 |
4 | Insider transactions | 1 | Aug 28, 2023 |
4 | Insider transactions | 1 | Aug 23, 2023 |
4 | Insider transactions | 1 | Aug 18, 2023 |
4 | Insider transactions | 1 | Aug 16, 2023 |
10-q | Quarterly Reports | 65 | Aug 11, 2023 |
8-k | 8K-related | 14 | Aug 10, 2023 |